10x Genomics, Inc. (TXG)

10x Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	355.78	359.28	227.35	596.07	688.64	476.49
Short-Term Investments	16.03	29.41	210.24	0	0	0
Cash & Cash Equivalents	371.81	388.7	437.59	596.07	688.64	476.49
Cash Growth	-12.67%	-11.17%	-26.59%	-13.44%	44.52%	579.85%
Receivables	91.31	114.83	104.21	85.25	51.21	33.37
Inventory	83.19	73.71	81.63	59.97	29.96	15.27
Other Current Assets	20.79	18.79	11.6	6.3	4.56	-44.29
Total Current Assets	567.09	596.02	635.04	747.59	774.37	480.84
Property, Plant & Equipment	332.34	344.93	359.21	230.41	119.82	48.82
Goodwill and Intangibles	20.64	21.13	27.37	29.91	22.35	0
Other Long-Term Assets	2.84	3.06	7.37	10.92	12.8	76.26
Total Long-Term Assets	355.82	369.12	393.95	271.24	154.98	125.08
Total Assets	922.91	965.14	1,029	1,019	929.34	605.92
Accounts Payable	20.22	15.74	21.6	17.35	4.71	13.03
Deferred Revenue	24.08	21.96	11.03	5.34	4.47	3.3
Current Debt	11.13	11.52	9.04	5.13	5.94	9.88
Other Current Liabilities	53.31	77.94	89.29	82.54	103.01	36.84
Total Current Liabilities	108.73	127.16	130.96	110.36	118.13	63.05
Long-Term Debt	81.05	83.85	86.14	76.85	57.04	19.84
Other Long-Term Liabilities	14.3	13.09	6.14	14.05	15.1	102.95
Total Long-Term Liabilities	95.35	96.94	92.28	90.9	72.14	122.79
Total Liabilities	204.08	224.1	223.24	201.26	190.27	185.84
Total Debt	92.18	95.37	95.18	81.98	62.98	29.72
Debt Growth	-9.67%	0.20%	16.10%	30.17%	111.91%	0.14%
Retained Earnings	-1,344.37	-1,284.42	-1,029.32	-863.32	-805.1	-262.37
Comprehensive Income	-0.46	-0.43	-4.34	0.02	-0.05	-0.05
Shareholders' Equity	718.83	741.04	805.74	817.57	739.07	420.08
Net Cash / Debt	279.64	293.33	342.42	514.1	625.67	446.77
Net Cash / Debt Growth	-13.62%	-14.34%	-33.39%	-17.83%	40.04%	1005.55%
Net Cash Per Share	2.34	2.50	3.01	4.66	6.19	11.43
Working Capital	458.36	468.86	504.08	637.23	656.24	417.79
Book Value Per Share	6.02	6.33	7.08	7.41	7.31	10.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).